ArticleOncotarget2018
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
Kimberley Hanson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ArticleOncotarget2018
Kimberley Hanson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.